Damora Therapeutics, Inc. (NASDAQ:DMRA)
| Market Cap | 1.25B+90.0% |
| Revenue (ttm) | 0 |
| Net Income | -262.83M-1483.9% |
| EPS | -4.27-850.3% |
| Shares Out | 61.55M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 488,751 |
| Open | 19.36 |
| Previous Close | 19.55 |
| Day's Range | 18.69 - 20.34 |
| 52-Week Range | 4.95 - 38.33 |
| Beta | 1.44 |
| Analysts | Buy |
| Price Target | 50.00(+147.04%) |
| Earnings Date | Nov 5, 2026 |
Damora Therapeutics, Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
About DMRA
Damora Therapeutics, Inc., a biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North America. The company’s lead product includes DMR-001, a investigational monoclonal antibody therapy that targets mutations in CALR, for the treatment of essential thrombocythemia; and DMR-002 and DMR-003, both anti-mutCALR-based therapies, with the intent to ultimately address the full spectrum of mutCALR MPN patients. It also develops GB3226, a small molecule inhibitor of ENL-YEATS and FLT3 for the treatment of acute myeloid leukemia. Damora Therapeutics, Inc. was founded in 2011 and is headquartered in Waltham, Massachusetts.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$DMRA stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in DMRA holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by DMRA's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
DMRA Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New DMRA patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to DMRA from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in DMRA
| ETF | Est. Holding Size |
|---|---|
| IWMiShares Russell 2000 ETF | $24.19M |
| XBIState Street SPDR S&P Biotech ETF | $14.82M |
| VTWOVanguard Russell 2000 ETF | $8.65M |
| VXFVanguard Extended Market ETF | $6.06M |
| IWOiShares Russell 2000 Growth ETF | $5.99M |
| SCHASchwab U.S. Small-Cap ETF | $5.06M |
Estimated from each fund’s disclosed top holdings × AUM
DMRA Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from DMRA’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score